ClinicalTrials.Veeva

Menu

Multifactorial Intervention on Diabetes (MIDiab Study)

S

Shandong First Medical University

Status and phase

Unknown
Phase 4

Conditions

Diabetes Mellitus, Type 2

Treatments

Behavioral: Lifestyle therapy
Other: General treatment
Drug: Pharmacotherapy
Other: Monitoring and management

Study type

Interventional

Funder types

Other

Identifiers

NCT03430284
2017YFC1309800

Details and patient eligibility

About

The prevalence of diabetes mellitus has been increasing in recent decades in China, and vascular complication is the major burden in patients with type 2 diabetes. Previous studies demonstrated that only glycemic control was not effective enough to prevent or improve diabetic vascular complications, but guidelines from the Chinese Diabetes Society and other national guidelines recommend an integrated multifactorial treatment approach. In this study, we aim to evaluate the effect on diabetic vascular complications of a multifactorial intervention comprising behavior modification, polypharmacological therapy and periodical monitoring in patients with type 2 diabetes.

Enrollment

6,300 estimated patients

Sex

All

Ages

35 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. 35-75 years old;
  2. diagnosed as type 2 diabetes according to the criteria of the World Health Organization in 1999.

Exclusion criteria

  1. type 1 diabetes,specific types of diabetes,gestational diabetes or pregestational diabetes;
  2. acute cardiovascular or cerebrovascular accidents within past 3 months;
  3. severe hepatic or renal dysfunction;
  4. malignant tumor;
  5. allergic history or contraindication for any drugs in trials;
  6. taking part in other clinical trials;
  7. obviously poor compliance.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

6,300 participants in 2 patient groups

Integrated Treatment
Experimental group
Treatment:
Drug: Pharmacotherapy
Behavioral: Lifestyle therapy
Other: Monitoring and management
General Treatment
Other group
Treatment:
Other: General treatment

Trial contacts and locations

2

Loading...

Central trial contact

Xu Hou

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems